SOURCE: Elsevier Business Intelligence

Elsevier Business Intelligence

October 12, 2009 11:08 ET

Business Development Execs From Major Multinational Medtech Companies Will Disclose Their Investing Needs/Wants at Elsevier Business Intelligence's 'IN3 Medical Device Summit' in San Francisco October 20-21

Becton Dickinson, Boston Scientific, Medtronic and Wright Medical Technology Will Comprise Panel: 'What Are the Large Device Companies Shopping For?'

SAN FRANCISCO, CA--(Marketwire - October 12, 2009) - Elsevier Business Intelligence, the medtech industry's leading strategic partner and investment conference organizer, announced today that it will host the largest annual strategic partnership and investment meeting, 'IN3 Medical Device Summit,' on October 20-21 at San Francisco's InterContinental Mark Hopkins Hotel. This event follows Elsevier Business Intelligence's 'Medical Device Investor Day,' also being held at the InterContinental Mark Hopkins, on October 19.

IN3 Medical Device Summit is the largest annual strategic partnership and investment meeting for senior-level medical technology executives. Hundreds of venture capital firms and medical technology companies are expected to attend IN3 Medical Device Summit on October 20 and 21 to hear about the latest innovations and investment opportunities from more than 50 emerging medical technology companies seeking funding and/or strategic partnerships.

Investment firms that are currently registered to attend or present at the IN3 Medical Device Summit include: Aberdare Ventures, Abingworth Management, Agate Medical Investments, Alta Partners, Arboretum Ventures, Ascension Health Ventures, Baird Venture Partners, CHL Medical Partners, Covidien Ventures, De Novo Ventures, Euclid SR Partners, Extera Partners, Frazier Healthcare Ventures, IDG Ventures, MB Venture Partners, Medventures Associates, Montreaux Equity Partners, ONSET Ventures, Polaris Venture Partners, Prospect Venture Partners, PTV Sciences, Safeguard Scientifics, Saints Capital, Sanderling Ventures, Scale Venture Partners, Skyline Ventures, US Venture Partners, Versant Ventures, and Waveland Capital Partners.

For more information about Medical Device Investor Day and IN3 Medical Device Summit, visit www.meddevicesummit.com or contact Kristy Grimes at 480-985-9512, 888-290-2225 (U.S. toll-free), or email IN3@elsevier.com.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier's 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year, in addition to offering a suite of innovative electronic products, such as Science Direct (www.sciencedirect.com), MDConsult (www.mdconsult.com), Nursing Consult (www.nursingconsult.com), Scopus (www.info.scopus.com), bibliographic databases, and online reference works.

Elsevier (www.elsevier.com) is a global business headquartered in Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of Reed Elsevier Group plc (www.reedelsevier.com), a world-leading publisher and information provider. Operating in the science and medical, legal, education and business-to-business sectors, Reed Elsevier provides high-quality and flexible information solutions to users, with increasing emphasis on the Internet as a means of delivery. Reed Elsevier's ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Contact Information

  • Contact:
    Ronald Trahan, APR
    Ronald Trahan Associates Inc.
    508-359-4005, x108